Event Description
Please note: This event is online only.
(Please contact organizer for Zoom link and ID)
Topic
The Neuropsychopharmacology of Psychedelic Drugs
Presented By
Frederick S. Barrett, PhD, associate professor of psychiatry and behavioral sciences, Johns Hopkins University School of Medicine; The John Hopkins Center for Psychedelic and Consciousness Research; Behavioral Pharmacology Research Unit
Learning Objectives
- Summarize current knowledge regarding the acute effects and potential neurobiological mechanisms underlying psychedelic drugs
- Evaluate the preliminary evidence for therapeutic efficacy of psychedelic drugs in patients experiencing mood and substance use disorders
- Discuss future directions for psychedelic research in psychiatry
Accredidation Statement
Tower Health is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicans.
Accredidation Statement
Drexel University College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure
The course director and members of the planning committee do not have any relevant financial relationships with any commercial interests to disclose regarding today's presentation.
Faculty and all others who have ability to control the content of continuing medical education activities sponsored by Tower Health are expected to disclose to the audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s). The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Frederick S. Barrett, PhD has no financial relationships to report in the last 24 months with an ineligible company. |
